Abbott is constantly searching for new ways to improve people's health. A critical success factor involves monitoring retroviruses and hepatitis viruses from around the globe with a surveillance program, to help ensure laboratory tests continue to accurately detect divergent virsuses, regardless of where they are acquired. Since 1994, Abbott's Global Viral Surveillance Program has been at the forefront of viral surveillance continually evolving to impact the development of next generation solutions.
Find the latest information in laboratory science, therapeutic areas and Abbott innovation.
Watch the webinar to hear from experts how you can realize the value within and beyond your laboratory walls with a TVO approach.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.